Los Angeles Capital Management & Equity Research Inc. bought a new stake in RTI Surgical Inc (NASDAQ:RTIX) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 76,766 shares of the medical equipment provider’s stock, valued at approximately $284,000.

Several other hedge funds also recently bought and sold shares of RTIX. BlackRock Inc. grew its stake in RTI Surgical by 1.0% during the 4th quarter. BlackRock Inc. now owns 5,007,470 shares of the medical equipment provider’s stock valued at $18,528,000 after purchasing an additional 50,239 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in RTI Surgical by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 4,662,902 shares of the medical equipment provider’s stock valued at $20,983,000 after purchasing an additional 101,811 shares in the last quarter. Vanguard Group Inc grew its stake in RTI Surgical by 15.0% during the 3rd quarter. Vanguard Group Inc now owns 2,883,306 shares of the medical equipment provider’s stock valued at $12,975,000 after purchasing an additional 375,027 shares in the last quarter. Vanguard Group Inc. grew its stake in RTI Surgical by 15.0% during the 3rd quarter. Vanguard Group Inc. now owns 2,883,306 shares of the medical equipment provider’s stock valued at $12,975,000 after purchasing an additional 375,027 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in RTI Surgical by 5.3% during the 3rd quarter. Renaissance Technologies LLC now owns 1,627,432 shares of the medical equipment provider’s stock valued at $7,323,000 after purchasing an additional 81,677 shares in the last quarter. Institutional investors and hedge funds own 71.35% of the company’s stock.

RTIX has been the subject of a number of recent analyst reports. Zacks Investment Research lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, January 17th. ValuEngine lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, November 27th. BidaskClub lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, December 4th. TheStreet upgraded RTI Surgical from a “c” rating to a “b-” rating in a research report on Thursday, March 7th. Finally, JMP Securities reiterated a “buy” rating and issued a $8.00 target price on shares of RTI Surgical in a research report on Wednesday, March 6th. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $6.25.

Shares of RTIX opened at $6.00 on Friday. The company has a market capitalization of $373.88 million, a PE ratio of 200.00 and a beta of 1.32. The company has a quick ratio of 1.22, a current ratio of 3.14 and a debt-to-equity ratio of 0.27. RTI Surgical Inc has a 52 week low of $3.51 and a 52 week high of $6.04.

RTI Surgical (NASDAQ:RTIX) last issued its earnings results on Thursday, February 28th. The medical equipment provider reported $0.04 EPS for the quarter, topping the consensus estimate of $0.01 by $0.03. RTI Surgical had a positive return on equity of 4.30% and a negative net margin of 0.45%.

TRADEMARK VIOLATION NOTICE: “76,766 Shares in RTI Surgical Inc (RTIX) Purchased by Los Angeles Capital Management & Equity Research Inc.” was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.mareainformativa.com/news/2019/03/17/76766-shares-in-rti-surgical-inc-rtix-purchased-by-los-angeles-capital-management-equity-research-inc.html.

RTI Surgical Profile

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Featured Article: Current Ratio

Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical Inc (NASDAQ:RTIX).

Institutional Ownership by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.